Farther Finance Advisors »

Fate Therapeutics shares owned by Farther Finance Advisors

Quarter-by-quarter ownership of Fate Therapeutics (FATE) shares owned by Farther Finance Advisors from 13F filings

Historical chart of Farther Finance Advisors investment in Fate Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Fate Therapeutics held by Farther Finance Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fate Therapeutics by Farther Finance Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $98 100 0.98
2024-06-30 $326 100 3.26
2022-12-31 $352 35 10.09

More positions owned by Farther Finance Advisors

Ishares Core S&p 500 Etf Etf (IVV)
Apple Stock (AAPL)
Vanguard S&p 500 Etf Etf (VOO)
Nvidia Corporation Stock (NVDA)
Vanguard Ftse Developed Markets Etf Etf (VEA)
Dimensional International Value Etf Etf (DFIV)
Microsoft Corp Stock (MSFT)
Schwab U.s. Large-cap Etf Etf (SCHX)
Ishares 0-3 Month Treasury Bond Etf Etf (SGOV)
Amazon Stock (AMZN)
Invesco Qqq Trust Series I Etf (QQQ)
Alphabet Inc Cap Stk Cl A Stock (GOOGL)
Ishares Core Msci Emerging Markets Etf Etf (IEMG)
Vanguard Short-term Corporate Bond Etf Etf (VCSH)
Vanguard Value Etf Etf (VTV)

View all positions for Farther Finance Advisors

Top funds holding Fate Therapeutics

Redmile Group
BlackRock
Vanguard Group
Wilshire Associates
Johnson & Johnson
Acadian Asset Management
Geode Capital Management
Renaissance Technologies
State Street Corporation
Vestal Point Capital
Dimensional Fund Advisors
Point72 Asset Management
Goldman Sachs Group
Tang Capital Management
AQR Capital Management

View all funds holding Fate Therapeutics